Trimethoprim-sulfamethoxazole-induced intrahepatic cholestasis

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Trimethoprim - sulfamethoxazole (Septra®) is used extensively in children for treatment of uninary tract infections. Recently, long-term prophylaxis with trimethoprim-sulfamethoxazole against urinary tract infection has been shown to be efficacious. Although sulfamethoxazole has occasionally been associated with hepatitis in which hepatocellular necrosis was the prominent feature trimethoprim has not been reported to cause hepatic injury. Intrahepatic cholestatis with hepatocellular necrosis from trimethoprim-sulfamethoxazole has been reported in a 16-year-old boy, but intrahepatic cholestatis without hepatocellular damage has been reported in children. This is a case report of a 5-year-old child in whom intrahepatic cholestatis developed after treatment with trimethoprim-sulfamethoxazole given for prophylaxis of urinary tract infection.

Original languageEnglish (US)
Pages (from-to)212-214
Number of pages3
JournalClinical Pediatrics
Volume22
Issue number3
StatePublished - 1983
Externally publishedYes

Fingerprint

Intrahepatic Cholestasis
Sulfamethoxazole Drug Combination Trimethoprim
Urinary Tract Infections
Necrosis
Sulfamethoxazole
Trimethoprim
Hepatitis
Liver
Wounds and Injuries
Therapeutics
Infection

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Trimethoprim-sulfamethoxazole-induced intrahepatic cholestasis. / Ghishan, Fayez K.

In: Clinical Pediatrics, Vol. 22, No. 3, 1983, p. 212-214.

Research output: Contribution to journalArticle

@article{5364a996d85040ae9fc226708dc7083a,
title = "Trimethoprim-sulfamethoxazole-induced intrahepatic cholestasis",
abstract = "Trimethoprim - sulfamethoxazole (Septra{\circledR}) is used extensively in children for treatment of uninary tract infections. Recently, long-term prophylaxis with trimethoprim-sulfamethoxazole against urinary tract infection has been shown to be efficacious. Although sulfamethoxazole has occasionally been associated with hepatitis in which hepatocellular necrosis was the prominent feature trimethoprim has not been reported to cause hepatic injury. Intrahepatic cholestatis with hepatocellular necrosis from trimethoprim-sulfamethoxazole has been reported in a 16-year-old boy, but intrahepatic cholestatis without hepatocellular damage has been reported in children. This is a case report of a 5-year-old child in whom intrahepatic cholestatis developed after treatment with trimethoprim-sulfamethoxazole given for prophylaxis of urinary tract infection.",
author = "Ghishan, {Fayez K}",
year = "1983",
language = "English (US)",
volume = "22",
pages = "212--214",
journal = "Clinical Pediatrics",
issn = "0009-9228",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Trimethoprim-sulfamethoxazole-induced intrahepatic cholestasis

AU - Ghishan, Fayez K

PY - 1983

Y1 - 1983

N2 - Trimethoprim - sulfamethoxazole (Septra®) is used extensively in children for treatment of uninary tract infections. Recently, long-term prophylaxis with trimethoprim-sulfamethoxazole against urinary tract infection has been shown to be efficacious. Although sulfamethoxazole has occasionally been associated with hepatitis in which hepatocellular necrosis was the prominent feature trimethoprim has not been reported to cause hepatic injury. Intrahepatic cholestatis with hepatocellular necrosis from trimethoprim-sulfamethoxazole has been reported in a 16-year-old boy, but intrahepatic cholestatis without hepatocellular damage has been reported in children. This is a case report of a 5-year-old child in whom intrahepatic cholestatis developed after treatment with trimethoprim-sulfamethoxazole given for prophylaxis of urinary tract infection.

AB - Trimethoprim - sulfamethoxazole (Septra®) is used extensively in children for treatment of uninary tract infections. Recently, long-term prophylaxis with trimethoprim-sulfamethoxazole against urinary tract infection has been shown to be efficacious. Although sulfamethoxazole has occasionally been associated with hepatitis in which hepatocellular necrosis was the prominent feature trimethoprim has not been reported to cause hepatic injury. Intrahepatic cholestatis with hepatocellular necrosis from trimethoprim-sulfamethoxazole has been reported in a 16-year-old boy, but intrahepatic cholestatis without hepatocellular damage has been reported in children. This is a case report of a 5-year-old child in whom intrahepatic cholestatis developed after treatment with trimethoprim-sulfamethoxazole given for prophylaxis of urinary tract infection.

UR - http://www.scopus.com/inward/record.url?scp=0020684055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020684055&partnerID=8YFLogxK

M3 - Article

C2 - 6600661

AN - SCOPUS:0020684055

VL - 22

SP - 212

EP - 214

JO - Clinical Pediatrics

JF - Clinical Pediatrics

SN - 0009-9228

IS - 3

ER -